November 20, 2023, Kronos Bio Inc (NASDAQ: KRON) trading session started at the price of $1.28, that was 8.11% jump from the session before. During the day, the shares moved up to $1.33 and dropped to $1.20 before settling in for the closing price of $1.11. A 52-week range for KRON has been $0.73 – $2.84.
When this article was written, the company’s average yearly earnings per share was at 13.08%. With a float of $38.69 million, this company’s outstanding shares have now reached $56.97 million.
Considering the fact that the conglomerate employs 97 people, you should pay attention to its efficiency factor.
Kronos Bio Inc (KRON) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Kronos Bio Inc stocks. The insider ownership of Kronos Bio Inc is 33.66%, while institutional ownership is 35.66%. The most recent insider transaction that took place on Nov 17, was worth 106,162. In this transaction President & CEO of this company bought 97,935 shares at a rate of $1.08, taking the stock ownership to the 2,540,665 shares. Before that another transaction happened on Nov 16, when Company’s President & CEO bought 262,433 for $1.00, making the entire transaction worth $261,514. This insider now owns 2,442,730 shares in total.
Kronos Bio Inc (KRON) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$0.54 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.51) by -$0.03. This company achieved a return on equity of -45.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.08% per share during the next fiscal year.
Kronos Bio Inc (NASDAQ: KRON) Trading Performance Indicators
You can see what Kronos Bio Inc (KRON) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.05 in one year’s time.
Technical Analysis of Kronos Bio Inc (KRON)
Compared to the last year’s volume of 0.3 million, its volume of 0.95 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 91.09%. Additionally, its Average True Range was 0.11.
During the past 100 days, Kronos Bio Inc’s (KRON) raw stochastic average was set at 30.08%, which indicates a significant decrease from 78.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.17% in the past 14 days, which was higher than the 78.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0671, while its 200-day Moving Average is $1.5139. Nevertheless, the first resistance level for the watch stands at $1.2867 in the near term. At $1.3733, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4167. If the price goes on to break the first support level at $1.1567, it is likely to go to the next support level at $1.1133. Should the price break the second support level, the third support level stands at $1.0267.
Kronos Bio Inc (NASDAQ: KRON) Key Stats
There are 58,317K outstanding shares of the company, which has a market capitalization of 69.98 million. As of now, sales total 0 K while income totals -133,200 K. Its latest quarter income was 1,860 K while its last quarter net income were -29,740 K.